Comparison of cryptococcal meningitis in HIV-negative patients with and without lung infections

J Int Med Res. 2020 Jun;48(6):300060520929591. doi: 10.1177/0300060520929591.

Abstract

Objective: To investigate the clinical features and outcomes of cryptococcal meningitis (CM) in HIV-negative patients with and without lung infections.

Methods: We retrospectively reviewed the medical records of HIV-negative patients with CM admitted to two university hospitals in Southwest China over the past 5 years.

Results: Seventy-one patients were included, of whom 35 (49.3%) had lung disease. Compared with patients without lung infection, CM patients with lung infection tended to be male and younger (≤30 years), experienced more fever, less vomiting and fewer central nervous system symptoms; more often had low white blood cell (WBC) counts (<20 × 106/L), and fewer often had ethmoid sinusitis, maxillary sinusitis, paranasal sinusitis, and otitis media. Cryptococcus neoformans isolates from these patients were sensitive to itraconazole, voriconazole, fluconazole, and amphotericin B but resistant to flucytosine. CM patients with lung infection had higher mortality at discharge compared with patients without lung infection (8.6% vs. 0%). Multivariable analyses showed that a WBC count <20 × 106/L was significantly associated with poor treatment outcome (odds ratio 0.01, 95% confidence interval 0-0.83).

Conclusion: HIV-negative CM patients with lung infections tended to be male and younger. Fever, fewer central nervous system symptoms, and WBC counts <20 × 106/L were characteristic of this patient group.

Keywords: diagnosis; Cryptococcal meningitis; clinical characteristics; cryptococcus neoformans; lung infection; patient outcomes.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • China / epidemiology
  • Cryptococcus neoformans / drug effects
  • Cryptococcus neoformans / immunology
  • Cryptococcus neoformans / isolation & purification*
  • Drug Resistance, Fungal
  • Female
  • Fever / drug therapy
  • Fever / epidemiology*
  • Fever / immunology
  • Fever / microbiology
  • Hospital Mortality
  • Humans
  • Leukocyte Count
  • Lung Diseases, Fungal / drug therapy
  • Lung Diseases, Fungal / epidemiology*
  • Lung Diseases, Fungal / immunology
  • Lung Diseases, Fungal / microbiology
  • Male
  • Meningitis, Cryptococcal / diagnosis*
  • Meningitis, Cryptococcal / immunology
  • Meningitis, Cryptococcal / microbiology
  • Meningitis, Cryptococcal / mortality
  • Microbial Sensitivity Tests
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Sex Factors
  • Treatment Outcome

Substances

  • Antifungal Agents